ConductScience.org, home

Library / Trial comparisons

Chronic HF Without SDB vs Chronic HF With SDB: NYHA Class ≥III

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

Measures 6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNoteSource
Risk in group 10.6960.6810.711wilsonClinicalTrials.gov
Risk in group 20.7340.7180.749wilsonClinicalTrials.gov
Risk difference, group 1 minus group 2-0.0377-0.059-0.0163newcombe hybrid scoreClinicalTrials.gov
Risk ratio, group 1 over group 20.9490.9210.977logClinicalTrials.gov
Odds ratio, group 1 over group 20.8310.7480.923logClinicalTrials.gov
Number needed to treat, for one fewer participant with the outcome on Chronic HF Without SDB than on Chronic HF With SDB26.51761.3from the risk difference intervalClinicalTrials.gov

Groups 2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov codeSource
Group 1Chronic HF Without SDB
Patients with chronic heart failure (left ventricular ejection fraction ≤45% or New York Heart Association (NYHA) class III or IV or NYHA class II with ≥1 hospitalization within 12 months before inclusion) and no sleep disordered breathing (SDB, Apnoea-Hypopnoea Index AHI ≥15)
2,5663,686OG000ClinicalTrials.gov
Group 2Chronic HF With SDB
Patients with chronic heart failure (left ventricular ejection fraction ≤45% or New York Heart Association (NYHA) class III or IV or NYHA class II with ≥1 hospitalization within 12 months before inclusion) and sleep disordered breathing (SDB, Apnoea-Hypopnoea Index AHI ≥15)
2,3413,190OG001ClinicalTrials.gov

Outcome 5

FieldValueSource
TypeSECONDARYClinicalTrials.gov
TitleNYHA Class ≥IIIClinicalTrials.gov
DescriptionNew York Heart Association Class III: Marked Limitation of physical activity. Comfortable at rest, but less than ordinary physical activity results in undue breathlessness, fatigue or palpitations.ClinicalTrials.gov
Time frameAt baseline, the NYHA was determined in a medical institution or taken restrospectively from medical recordsClinicalTrials.gov
PopulationClinicalTrials.gov

Trial 8

FieldValueSource
TitleSleep-Disordered Breathing in Heart Failure - The SchlaHF-RegistryClinicalTrials.gov
NCT numberNCT01500759ClinicalTrials.gov
PhasesClinicalTrials.gov
ConditionsCongestive Heart Failure, Left Ventricular Systolic DysfunctionClinicalTrials.gov
InterventionsClinicalTrials.gov
Lead sponsorResMedClinicalTrials.gov
Results first posted2020-07-09ClinicalTrials.gov
Results on ClinicalTrials.govhttps://clinicaltrials.gov/study/NCT01500759?tab=resultsClinicalTrials.gov

Source 4

FieldValueSource
Releasetrial-comparisons-2026-03-23-0.1.0ClinicalTrials.gov
Release manifest SHA-256f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57ClinicalTrials.gov
AACT copy2026-03-23ClinicalTrials.gov
Tables readoutcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquetClinicalTrials.gov

The same record as JSON

Release trial-comparisons-2026-03-23-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.